Menu Search
Equities

Assura PLC

75A:DEU

Assura PLC

Actions
  • Price (EUR)0.482
  • Today's Change-0.014 / -2.82%
  • Shares traded100.00
  • 1 Year change-15.59%
  • Beta--
Data delayed at least 15 minutes, as of May 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care, and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests, and treatments in the community. The Company owns and manages a portfolio of about 612 properties. The Company’s subsidiaries include Assura (SC1) Ltd, BHE (St James) Ltd, Assura PCP UK Ltd, Metro MRI Ltd, Upton Community Health Care Ltd, Cheltenham Family Health Care Centre Ltd, Upton Medical Ltd, Xantaris Investments (XXI) Ltd, Assura Services Ltd, Assura Primary Care Properties Ltd, Assura Trellech Ltd, and others.

  • Revenue in GBP (TTM)157.80m
  • Net income in GBP-28.80m
  • Incorporated2014
  • Employees71.00
  • Location
    Assura PLC3 Barrington RoadALTRINCHAM WA14 1GYUnited KingdomGBR
  • Phone+44 161 552 4506
  • Fax+44 192 523 4503
  • Websitehttps://www.assuraplc.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.